Send me real-time posts from this site at my email
Chris L

Buy Bristol-Myers (BMY)

$BMY is down after good results.

Street doesn’t believe they can replace the Revlimid lost profits starting in 2022. I’m more than willing to be patient, collect the 3.5% dividend and following the strengthening balance sheet.

$BMY, Bristol-Myers Squibb Company / H1

notes via user

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue